SUPN – supernus pharmaceuticals, inc. (US:NASDAQ)

News

Lupin Launches Topiramate Extended-Release Capsules in the United States [Yahoo! Finance]
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Zacks Research from a "hold" rating to a "strong sell" rating.
Supernus Pharmaceuticals (NASDAQ:SUPN) was downgraded by analysts at Wal
2 Cash-Producing Stocks to Consider Right Now and 1 Facing Headwinds [Yahoo! Finance]
Is Supernus Pharmaceuticals (SUPN) Still Attractive After Strong Multi-Year Share Price Gains [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com